Monocytes/macrophages are vital for host-immune responses and have been implicated in the pathogenesis of rheumatoid arthritis (RA). We demonstrated that PI3K/Akt-1-dependent Mcl-1 expression is vital for macrophage survival. Suppression of PI3K/Akt reduced Mcl-1 expression, resulting in apoptosis mediated through the mitochondrial pathway. Forced downregulation of Mcl-1 through antisense oligonucleotides also induced apoptosis, demonstrating that Mcl-1 is essential for macrophage viability. Further, our preliminary data suggested that Mcl-1 may also be regulated by the JAK/STAT pathway in human macrophages. Therefore, we propose to determine the mechanisms by which the PI3K/Akt and JAK/STAT3 pathways contribute to the regulation of Mcl-1 in macrophages. Additionally, we will identify the mechanism by which Mcl-1 protects macrophages by examining the interaction of Mcl-1 with pro-apoptotic molecules, such as Bax in macrophages to delineate the mechanism of mitochondrial dysfunction that occurs following Mcl-1 ablation. Our preliminary data suggests that Mcl-1 may be important in the in maintaining the viability of RA synovial macrophages. Additionally, our preliminary data has revealed that in vitro, Mcl-1 was highly expressed in RA, compared to osteoarthritis (OA), synovial fibroblasts. Mcl-1 was also strongly expressed in the synovium of rats with adjuvant-induced arthritis (AIA). Therefore, we propose to characterize the expression and function of Mcl-1 in the RA joint, examining macrophages and synovial fibroblasts. We propose to determine if the forced downregulation of Mcl-1 will ameliorate experimental arthritis, which would indicate that Mcl-1 is a contributor to the initiation and/or progression of arthritis. Thus, this proposal will delineate the mechanisms regulating the expression and the novel functions of Mcl-1 in macrophages. Further studies are proposed to delineate potential cell type-specific differences between macrophages and normal, osteoarthritis and rheumatoid arthritis synovial fibroblasts. These experiments will provide new and important information concerning the novel role of Mcl-1, which may provide insights that will lead to the development of improved therapy for patients with RA.
Scatizzi, John C; Hutcheson, Jack; Pope, Richard M et al. (2010) Bim-Bcl-2 homology 3 mimetic therapy is effective at suppressing inflammatory arthritis through the activation of myeloid cell apoptosis. Arthritis Rheum 62:441-51 |
Gierut, Angelica; Perlman, Harris; Pope, Richard M (2010) Innate immunity and rheumatoid arthritis. Rheum Dis Clin North Am 36:271-96 |
Scatizzi, John C; Mavers, Melissa; Hutcheson, Jack et al. (2009) The CDK domain of p21 is a suppressor of IL-1beta-mediated inflammation in activated macrophages. Eur J Immunol 39:820-5 |
Shi, Bo; Tran, Tri; Sobkoviak, Rudina et al. (2009) Activation-induced degradation of FLIP(L) is mediated via the phosphatidylinositol 3-kinase/Akt signaling pathway in macrophages. J Biol Chem 284:14513-23 |
Tran, Tri M; Temkin, Vladislav; Shi, Bo et al. (2009) TNFalpha-induced macrophage death via caspase-dependent and independent pathways. Apoptosis 14:320-32 |
Liu, Hongtao; Shi, Bo; Huang, Chiang-Ching et al. (2008) Transcriptional diversity during monocyte to macrophage differentiation. Immunol Lett 117:70-80 |
Shahrara, Shiva; Huang, Qiquan; Mandelin 2nd, Arthur M et al. (2008) TH-17 cells in rheumatoid arthritis. Arthritis Res Ther 10:R93 |
Huang, Qi-Quan; Hossain, M Moazzem; Wu, Kaichun et al. (2008) Role of H2-calponin in regulating macrophage motility and phagocytosis. J Biol Chem 283:25887-99 |
Shahrara, Shiva; Proudfoot, Amanda E I; Park, Christy C et al. (2008) Inhibition of monocyte chemoattractant protein-1 ameliorates rat adjuvant-induced arthritis. J Immunol 180:3447-56 |
Pope, Richard M; Tschopp, Jurg (2007) The role of interleukin-1 and the inflammasome in gout: implications for therapy. Arthritis Rheum 56:3183-8 |
Showing the most recent 10 out of 25 publications